vs

Side-by-side financial comparison of APOGEE ENTERPRISES, INC. (APOG) and Privia Health Group, Inc. (PRVA). Click either name above to swap in a different company.

Privia Health Group, Inc. is the larger business by last-quarter revenue ($541.2M vs $351.4M, roughly 1.5× APOGEE ENTERPRISES, INC.). APOGEE ENTERPRISES, INC. runs the higher net margin — 4.7% vs 1.7%, a 3.0% gap on every dollar of revenue. On growth, Privia Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs 1.6%). Over the past eight quarters, Privia Health Group, Inc.'s revenue compounded faster (14.2% CAGR vs 2.9%).

Apogee Electronics is an American manufacturer of audio interfaces, analog-to-digital and digital-to-analog converters, USB & iOS microphones, and audio production software.

Privia Health Group, Inc. is a U.S.-headquartered healthcare technology and services firm supporting independent practices, health systems, and payers delivering value-based care. It offers population health tools, patient engagement platforms, care coordination support, and workflow solutions to boost patient outcomes and cut operational costs for U.S. healthcare stakeholders.

APOG vs PRVA — Head-to-Head

Bigger by revenue
PRVA
PRVA
1.5× larger
PRVA
$541.2M
$351.4M
APOG
Growing faster (revenue YoY)
PRVA
PRVA
+15.8% gap
PRVA
17.4%
1.6%
APOG
Higher net margin
APOG
APOG
3.0% more per $
APOG
4.7%
1.7%
PRVA
Faster 2-yr revenue CAGR
PRVA
PRVA
Annualised
PRVA
14.2%
2.9%
APOG

Income Statement — Q4 FY2026 vs Q4 FY2025

Metric
APOG
APOG
PRVA
PRVA
Revenue
$351.4M
$541.2M
Net Profit
$16.6M
$9.2M
Gross Margin
22.4%
Operating Margin
7.3%
2.1%
Net Margin
4.7%
1.7%
Revenue YoY
1.6%
17.4%
Net Profit YoY
568.8%
108.0%
EPS (diluted)
$0.78
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APOG
APOG
PRVA
PRVA
Q1 26
$351.4M
Q4 25
$348.6M
$541.2M
Q3 25
$358.2M
$580.4M
Q2 25
$346.6M
$521.2M
Q1 25
$345.7M
$480.1M
Q4 24
$341.3M
$460.9M
Q3 24
$342.4M
$437.9M
Q2 24
$331.5M
$422.3M
Net Profit
APOG
APOG
PRVA
PRVA
Q1 26
$16.6M
Q4 25
$16.5M
$9.2M
Q3 25
$23.6M
$6.9M
Q2 25
$-2.7M
$2.7M
Q1 25
$2.5M
$4.2M
Q4 24
$21.0M
$4.4M
Q3 24
$30.6M
$3.5M
Q2 24
$31.0M
$3.5M
Gross Margin
APOG
APOG
PRVA
PRVA
Q1 26
22.4%
Q4 25
23.8%
Q3 25
23.1%
Q2 25
21.7%
Q1 25
21.6%
Q4 24
26.1%
Q3 24
28.4%
Q2 24
29.8%
Operating Margin
APOG
APOG
PRVA
PRVA
Q1 26
7.3%
Q4 25
7.1%
2.1%
Q3 25
7.5%
2.5%
Q2 25
2.0%
0.6%
Q1 25
1.8%
1.1%
Q4 24
8.4%
1.1%
Q3 24
12.3%
1.3%
Q2 24
12.5%
1.2%
Net Margin
APOG
APOG
PRVA
PRVA
Q1 26
4.7%
Q4 25
4.7%
1.7%
Q3 25
6.6%
1.2%
Q2 25
-0.8%
0.5%
Q1 25
0.7%
0.9%
Q4 24
6.1%
1.0%
Q3 24
8.9%
0.8%
Q2 24
9.4%
0.8%
EPS (diluted)
APOG
APOG
PRVA
PRVA
Q1 26
$0.78
Q4 25
$0.77
$0.08
Q3 25
$1.10
$0.05
Q2 25
$-0.13
$0.02
Q1 25
$0.12
$0.03
Q4 24
$0.96
$0.03
Q3 24
$1.40
$0.03
Q2 24
$1.41
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APOG
APOG
PRVA
PRVA
Cash + ST InvestmentsLiquidity on hand
$39.5M
$479.7M
Total DebtLower is stronger
$232.3M
Stockholders' EquityBook value
$511.8M
$737.2M
Total Assets
$1.1B
$1.4B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APOG
APOG
PRVA
PRVA
Q1 26
$39.5M
Q4 25
$41.3M
$479.7M
Q3 25
$39.5M
$441.4M
Q2 25
$32.8M
$390.1M
Q1 25
$41.4M
$469.3M
Q4 24
$43.9M
$491.1M
Q3 24
$51.0M
$422.0M
Q2 24
$30.4M
$387.4M
Total Debt
APOG
APOG
PRVA
PRVA
Q1 26
$232.3M
Q4 25
Q3 25
Q2 25
Q1 25
$285.0M
Q4 24
Q3 24
Q2 24
Stockholders' Equity
APOG
APOG
PRVA
PRVA
Q1 26
$511.8M
Q4 25
$512.3M
$737.2M
Q3 25
$500.2M
$709.1M
Q2 25
$481.8M
$682.9M
Q1 25
$487.9M
$659.4M
Q4 24
$522.1M
$635.2M
Q3 24
$506.4M
$614.9M
Q2 24
$480.0M
$595.4M
Total Assets
APOG
APOG
PRVA
PRVA
Q1 26
$1.1B
Q4 25
$1.1B
$1.4B
Q3 25
$1.2B
$1.4B
Q2 25
$1.2B
$1.3B
Q1 25
$1.2B
$1.2B
Q4 24
$1.2B
$1.1B
Q3 24
$917.1M
$1.1B
Q2 24
$889.0M
$1.1B
Debt / Equity
APOG
APOG
PRVA
PRVA
Q1 26
0.45×
Q4 25
Q3 25
Q2 25
Q1 25
0.58×
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APOG
APOG
PRVA
PRVA
Operating Cash FlowLast quarter
$122.5M
$127.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
7.8%
Cash ConversionOCF / Net Profit
7.37×
13.93×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APOG
APOG
PRVA
PRVA
Q1 26
$122.5M
Q4 25
$29.3M
$127.5M
Q3 25
$57.1M
$52.0M
Q2 25
$-19.8M
$8.0M
Q1 25
$30.0M
$-24.1M
Q4 24
$31.0M
$74.8M
Q3 24
$58.7M
$33.2M
Q2 24
$5.5M
$34.5M
Free Cash Flow
APOG
APOG
PRVA
PRVA
Q1 26
Q4 25
$22.9M
Q3 25
$52.4M
Q2 25
$-26.9M
Q1 25
$19.1M
Q4 24
$22.0M
Q3 24
$50.2M
Q2 24
$-1.8M
FCF Margin
APOG
APOG
PRVA
PRVA
Q1 26
Q4 25
6.6%
Q3 25
14.6%
Q2 25
-7.8%
Q1 25
5.5%
Q4 24
6.4%
Q3 24
14.7%
Q2 24
-0.5%
Capex Intensity
APOG
APOG
PRVA
PRVA
Q1 26
7.8%
Q4 25
1.9%
Q3 25
1.3%
Q2 25
2.1%
Q1 25
3.2%
Q4 24
2.6%
Q3 24
2.5%
Q2 24
2.2%
Cash Conversion
APOG
APOG
PRVA
PRVA
Q1 26
7.37×
Q4 25
1.77×
13.93×
Q3 25
2.41×
7.58×
Q2 25
2.97×
Q1 25
12.08×
-5.70×
Q4 24
1.48×
17.00×
Q3 24
1.92×
9.38×
Q2 24
0.18×
9.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APOG
APOG

Architectural Services$127.1M36%
Architectural Metals$110.0M31%
Architectural Glass$67.4M19%
Performance Surfaces$54.3M15%

PRVA
PRVA

FFS Patient Care$364.4M67%
Capitated Revenue$71.4M13%
Shared Savings$46.9M9%
FFS Administrative Services$36.0M7%
Care Management Fee PMPM$20.0M4%
Other Revenue$2.5M0%

Related Comparisons